A new compound, called VU319, has delivered promising results in a Phase 1 trial for treating Alzheimer’s disease and other neudegenerative conditions. The corresponding study was published in ACS ...
A study published in The British Medical Journal explored the relationship between occupation and Alzheimer’s disease mortality, focusing on occupations involving extensive real-time navigation, such ...
"Misfolded t-shirts are PrPC proteins that collect on ... Early symptoms may seem similar to those of dementia or Alzheimer's disease. Symptoms of FFI are life-threatening and there is currently ...